| Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function B Salzer, CM Schueller, CU Zajc, T Peters, MA Schoeber, B Kovacic, ... Nature Communications 11 (1), 4166, 2020 | 68 | 2020 |
| EZH2 inhibition as new epigenetic treatment option for pancreatic neuroendocrine neoplasms (PanNENs) SL April-Monn, V Andreasi, M Schiavo Lena, MC Sadowski, C Kim-Fuchs, ... Cancers 13 (19), 5014, 2021 | 11 | 2021 |
| BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression A Tancredi, O Gusyatiner, P Bady, MC Buri, R Lomazzi, D Chiesi, ... Cell Death & Disease 13 (12), 1037, 2022 | 7 | 2022 |
| Epigenetic silencing of HTATIP2 in glioblastoma contributes to treatment resistance by enhancing nuclear translocation of the DNA repair protein MPG TT Nguyen, P Rajakannu, MDT Pham, L Weman, A Jucht, MC Buri, ... Molecular Oncology 17 (9), 1744-1762, 2023 | 2 | 2023 |
| Neuroblastoma-associated chromosomal aberrations drive cell identity loss in human neural crest via disruption of developmental regulators IM Saldana-Guerrero, LF Montano-Gutierrez, C Hafemeister, D Stavish, ... Cold Spring Harbor Laboratory, 2022 | 1 | 2022 |
| A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations IM Saldana-Guerrero, LF Montano-Gutierrez, K Boswell, C Hafemeister, ... Nature Communications 15 (1), 3745, 2024 | | 2024 |
| NK cells shape the clonal evolution of B cell leukaemia by IFN-γ production MC Buri, MR Shoeb, A Bykov, P Repiscak, H Baik, A Dupanovic, ... bioRxiv, 2023.11. 16.567430, 2023 | | 2023 |
| A stem cell model dissects detrimental effects of neuroblastoma-linked chromosomal aberrations on cell differentiation during neural crest development IM Saldana-Guerrero, LF Montano-Gutierrez, C Hafemeister, D Stavish, ... Cancer Research 83 (7_Supplement), 3542-3542, 2023 | | 2023 |
| Epigenetic silencing of HTATIP2 in glioblastoma enhances nuclear translocation of the DNA-repair protein MPG affecting treatment resistance M Hegi, TT Nguyen, P Rajakannu, MDT Pham, L Weman, A Jucht, M Buri, ... | | 2022 |
| How do leukemic cells escape natural killer cell-mediated surveillance? Uncovering novel immune evasion mechanism (s) MC Buri, P Repiscak, M Shoeb, FO David, B Kovacic, H Baik, ... EUROPEAN JOURNAL OF IMMUNOLOGY 52, 296-296, 2022 | | 2022 |
